During the past decade, UCSD Jacobs Retina Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSD Jacobs Retina Center" #1 sponsor was "Kodiak Sciences Inc" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "UCSD Jacobs Retina Center" are "Macular Degeneration" (2 trials), "Macular Edema" (2 trials), "Retinal Vein Occlusion" (2 trials), "Wet Macular Degeneration" (2 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "UCSD Jacobs Retina Center" in a lesser frequency.

Most popular intervention types in "UCSD Jacobs Retina Center" are "Drug" (9 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (5 trials), "Sham Procedure" (5 trials), "KSI-301" (4 trials), "Faricimab" (1 trials) and "IONIS-FB-LRx" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Jacobs Retina Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "UCSD Jacobs Retina Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UCSD Jacobs Retina Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Jacobs Retina Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".